FDA, working to tackle pandemic inspection backlog, struggles with foreign oversight and site visits for new drugs fkansteiner Tue, 11/23/2021 – 13:14 More: FDA, working to tackle pandemic inspection backlog, struggles with foreign oversight and site visits for new drugs
read moreSanofi coughs up $180M to settle Pompe disease royalty payment dispute aliu Tue, 11/23/2021 – 12:06 More: Sanofi coughs up 0M to settle Pompe disease royalty payment dispute Source: fierce
read moreAstraZeneca CEO questions mRNA vaccine superiority, raising theory that his company’s shot offers longer-lasting protection kdunleavy Tue, 11/23/2021 – 09:54 More: AstraZeneca CEO questions mRNA vaccine superiority, raising theory that his company's shot offers longer-lasting protection Source: fierce
read morePfizer to become $100B behemoth next year thanks to COVID-19 drug and vaccine: analyst aliu Tue, 11/23/2021 – 09:52 More: Pfizer to become 0B behemoth next year thanks to COVID-19 drug and vaccine: analyst Source: fierce
read moreClosed-loop system offers promise of automated overdose therapy ntaylor Tue, 11/23/2021 – 09:15 More: Closed-loop system offers promise of automated overdose therapy Source: fierce
read moreNICE has published draft guidance recommending risdiplam (Evrysdi) as part of a managed access agreement (MAA) for the treatment of the rare genetic disorder spinal muscular atrophy (SMA). More: NICE recommends risdiplam for spinal muscular atrophy Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals